Cargando…

Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer: A meta-analysis

BACKGROUNDS: Numerous studies have reported that aberrant pyruvate kinase M2 isoform (PKM2) expressed in cancer, indicating that PKM2 plays a critical role in tumor initiation and progression. Nevertheless, its prognostic value in breast cancer tumor is yet contentious. Therefore, we performed this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yiming, Wu, Ke, Liu, Yulin, Shi, Liang, Tao, Kaixiong, Wang, Guobin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	5750
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704850/ https://www.ncbi.nlm.nih.gov/pubmed/29145305 http://dx.doi.org/10.1097/MD.0000000000008690

Ejemplares similares

Expression and clinical significance of pyruvate kinase M2 in breast cancer: A protocol for meta-analysis and bioinformatics validation analysis
por: Li, Huayan, et al.
Publicado: (2021)

Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis
por: Sun, Xi, et al.
Publicado: (2017)

Prognostic significance of lymphatic vessel invasion diagnosed by D2-40 in Chinese invasive breast cancers
por: He, Ke-Wen, et al.
Publicado: (2017)

Comprehensive analysis of NT5DC family prognostic and immune significance in breast cancer
por: Jia, Yiwei, et al.
Publicado: (2023)

Prognostic significance of preoperative albumin to fibrinogen ratio associated nomograms in patients with breast invasive ductal carcinoma
por: Zheng, Lihua, et al.
Publicado: (2020)

Prognostic Significance of Preoperative Circulating Monocyte Count in Patients With Breast Cancer: Based on a Large Cohort Study
por: Wen, Jiahuai, et al.
Publicado: (2015)

Prognostic significance of TP53 and PIK3CA mutations analyzed by next-generation sequencing in breast cancer
por: Choi, Jin Hyuk, et al.
Publicado: (2023)

Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients: A meta-analysis
por: Liu, Xu, et al.
Publicado: (2017)

Expression of mammalian sterile 20-like kinase 1 and 2 and Yes-associated protein 1 proteins in triple-negative breast cancer and the clinicopathological significance
por: Feng, Yang, et al.
Publicado: (2021)

Prognostic value of programmed cell death ligand-1 expression in breast cancer: A meta-analysis
por: Zhang, Yingzi, et al.
Publicado: (2020)

Prognostic significance of molecular subtype, metastatic site and primary tumor surgery for survival in primary metastatic breast cancer: A SEER-based study
por: Li, Yang, et al.
Publicado: (2021)

Prognostic value of long non-coding RNAs in triple negative breast cancer: A PRISMA-compliant meta-analysis
por: Zhang, Shuo, et al.
Publicado: (2020)

Prognosis and clinicopathological characteristics of metaplastic breast cancer: A meta-analysis
por: Yang, Xiaolu, et al.
Publicado: (2022)

The effects of case management for breast cancer patients: A protocol for systematic review and meta-analysis
por: Chai, Yong, et al.
Publicado: (2022)

Prognostic role of methylated GSTP1, p16, ESR1 and PITX2 in patients with breast cancer: A systematic meta-analysis under the guideline of PRISMA
por: Sheng, Xianneng, et al.
Publicado: (2017)

Prognostic value of IMP3 immunohistochemical expression in triple negative breast cancer
por: Sjekloča, Nikoleta, et al.
Publicado: (2020)

Induced abortion and breast cancer: An updated meta-analysis
por: Deng, Yongchun, et al.
Publicado: (2018)

Long non-coding RNA-based signatures to improve prognostic prediction of breast cancer
por: Zhang, Yi, et al.
Publicado: (2020)

High peroxidasin-like expression is a potential and independent prognostic biomarker in breast cancer
por: Li, Yanqing, et al.
Publicado: (2019)

ANO6 is a reliable prognostic biomarker and correlates to macrophage polarization in breast cancer
por: Tang, Long-Huan, et al.
Publicado: (2023)

Association between CASC16 rs4784227 polymorphism and breast cancer susceptibility: A meta-analysis
por: Liang, Xiong-Shun, et al.
Publicado: (2021)

Utility of Red Cell Distribution Width as a Prognostic Factor in Young Breast Cancer Patients
por: Huang, Du-Ping, et al.
Publicado: (2016)

Exploring immune-related genes with prognostic value in microenvironment of breast cancer from TCGA database
por: Yang, Hao, et al.
Publicado: (2020)

Mining immune-related genes with prognostic value in the tumor microenvironment of breast invasive ductal carcinoma
por: He, Qiang, et al.
Publicado: (2021)

Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis
por: Tao, Miaomiao, et al.
Publicado: (2017)

Prognostic utility of FDG PET/CT and bone scintigraphy in breast cancer patients with bone-only metastasis
por: Park, Soyeon, et al.
Publicado: (2017)

Identification of prognostic genes for early basal-like breast cancer with weighted gene co-expression network analysis
por: Yuan, Keyu, et al.
Publicado: (2022)

Vitamin D Receptor Polymorphism and Breast Cancer Risk: A Meta-Analysis
por: Lu, Demin, et al.
Publicado: (2016)

CONSORT-Independent prognostic value of asphericity of pretherapeutic F-18 FDG uptake by primary tumors in patients with breast cancer
por: Jung, Ji-hoon, et al.
Publicado: (2017)

Prognostic disparities in young patients based on breast cancer subtype: A population-based study from the SEER database
por: Chen, Bing, et al.
Publicado: (2023)

Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis
por: Zhao, Xiao-Bo, et al.
Publicado: (2016)

The efficacy of gefitinib supplementation for breast cancer: A meta-analysis of randomized controlled studies
por: Ye, Jing, et al.
Publicado: (2020)

Effect of aspirin use on survival benefits of breast cancer patients: A meta-analysis
por: Liu, Jiamin, et al.
Publicado: (2021)

Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis
por: Liu, Yulin, et al.
Publicado: (2016)

Positive estrogen receptor status is a poor prognostic factor in node-negative breast cancer: An observational study in Asian patients
por: Jung, Eun Jung, et al.
Publicado: (2021)

Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis
por: Baretta, Zora, et al.
Publicado: (2016)

MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis
por: Lü, Lingshuang, et al.
Publicado: (2017)

Prognosis of COVID-19 in patients with breast cancer: A protocol for systematic review and meta-analysis
por: Sheng, Zhijuan, et al.
Publicado: (2020)

The relationship between exposure to particulate matter and breast cancer incidence and mortality: A meta-analysis
por: Zhang, Zhe, et al.
Publicado: (2019)

LEP as a potential biomarker in prognosis of breast cancer: Systemic review and meta analyses (PRISMA)
por: Jin, Tong Yi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1ovk63l31hvv68kamhdc828qg3